Healthcare leaders spend significant time discussing unsustainable costs. Rising utilization, increasing Medicare expenditures, workforce shortages, narrowing margins, and growing demand from an aging population dominate strategic planning conversations across the industry.
Too often, however, these challenges are discussed independently, as though they stem from different causes and require different solutions.
Increasingly, that assumption deserves scrutiny.
Many of healthcare’s most significant financial challenges originate in the same place: a system that has historically been better at financing intervention than financing prevention.
We can respond to disease progression, acute events, and complex episodes of care, but we’ve been far less effective at creating economic models that support the work required to prevent those outcomes from occurring in the first place.
The scale of that challenge is difficult to overstate. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending reached $5.3 trillion in 2024, accounting for 18.0% of the nation’s GDP. Medicare spending alone exceeded $1.1 trillion, representing approximately 21% of total national health expenditures. CMS projects healthcare spending will continue to outpace economic growth over the next decade, reaching 20.6% of GDP by 2034. 1
Where the real cost begins
The result is a healthcare system that frequently spends more treating the consequences of declining health than preserving health itself.
Patients experience this reality in profoundly human ways: avoidable hospitalizations, fragmented care, loss of independence, preventable disease progression, and missed opportunities for intervention. Health systems experience it through rising costs, resource constraints, workforce pressures, and increasing demand for complex care.
This is where the value-based care conversation is often misunderstood.
The most compelling case for value-based care is not simply about reimbursement methodology, risk contracts, or shared savings programs. It is ultimately about whether healthcare organizations have the incentives, infrastructure, and resources necessary to intervene early enough to meaningfully alter patient trajectories before expensive complications emerge.
In that sense, the financial case and the patient case for value-based care are not competing arguments but often the same one viewed through different lenses.
The opportunity comes before the cost
One of the most important realities in healthcare economics is that spending is highly concentrated. A relatively small percentage of patients account for a disproportionate share of healthcare expenditures, with costs tending to accumulate around chronic disease progression, acute episodes of care, preventable utilization, and loss of function.
Recent analysis from KFF found that 5% of the U.S. population accounted for nearly half of all healthcare spending in 2023, while the highest-cost 1% of patients averaged more than $150,000 in annual expenditures. 2
The challenge for healthcare organizations is that these costly events are highly visible while the factors that create them often are not.
A hospitalization for heart failure rarely begins with the hospitalization itself, just as a preventable readmission rarely begins at discharge. More often, the pathway starts weeks or months earlier when a patient misses medications, delays follow-up care, struggles to navigate referrals, or encounters social barriers that make adherence difficult.
By the time the financial consequences occur, the opportunity for a lower-cost intervention has frequently passed.
Traditional fee-for-service reimbursement was designed around encounters. It rewards activities that occur within the visit and measures value largely through services rendered. While that model has been extraordinarily effective at expanding access and supporting medical innovation, it was never designed to fund extensive longitudinal management of patient risk.
Much of what drives healthcare costs, however, happens outside the encounter.
Medication adherence, chronic disease management, behavioral health needs, transportation barriers, caregiver support, and care coordination frequently determine whether a patient remains stable or progresses toward a more expensive episode of care.
Yet, historically, these activities have received a fraction of the attention and investment devoted to acute intervention, creating a structural imbalance: Healthcare organizations spend heavily managing the consequences of risk while often underinvesting in identifying and mitigating risk earlier.
Value-based care begins to change that economic equation.
When organizations become accountable for outcomes over time rather than activity at a point in time, investing in care management, risk identification, patient engagement, and continuity becomes financially rational. Activities once viewed as overhead become some of the most effective tools available for improving outcomes while reducing avoidable cost.
The result is not simply lower spending; it’s healthier patients whose needs are addressed earlier, when interventions are often both more effective and less expensive.
Why patient complexity is an economic variable
Perhaps no aspect of value-based care illustrates this shift more clearly than how organizations think about patient complexity.
Historically, documentation has often been viewed as an administrative responsibility. For many physicians, it can feel disconnected from the direct act of patient care. Yet from a healthcare management perspective, documentation serves a far larger purpose: It determines how accurately organizations understand the populations they are responsible for serving.
Every healthcare strategy depends on visibility.
Organizations allocate resources based on perceived need, develop population health programs based on measured risk, and build staffing models, care management teams, and support services based on projected demand.
This becomes particularly relevant within Medicare populations, where multiple chronic conditions, functional limitations, social determinants of health, and behavioral health needs frequently interact in ways that significantly influence future utilization patterns. These patients often require substantially more support than traditional healthcare delivery models were designed to provide.
The economics become even more pronounced among older adults. CMS data show that annual per-person healthcare spending for Americans ages 65 and older exceeds $22,000 per year, more than five times higher than spending for children and more than twice the spending of working-age adults. 3
Better visibility changes resource allocation
When complexity is understood accurately, care teams are better positioned to identify patients at elevated risk, anticipate future needs, coordinate interventions, and direct support toward individuals most likely to benefit from additional resources.
If those realities remain invisible and patient complexity is not fully understood, healthcare organizations are effectively making resource allocation decisions with incomplete information. Resources may be directed toward treating consequences rather than addressing causes, and interventions may occur after deterioration rather than before it.
Viewed through this lens, the patient story is also a financial one.
It’s not because documentation exists to improve reimbursement but because accurate understanding enables better forecasting, earlier intervention, more efficient deployment of finite resources, and stronger population health management.
The highest-value investments in healthcare often don’t generate revenue
A second misconception within healthcare economics is the assumption that the most valuable interventions are necessarily the most technologically advanced or clinically complex.
In reality, some of the highest-return activities in healthcare are remarkably practical: care coordination, medication education, transportation support, behavioral health integration, caregiver training, post-discharge outreach, and community-based support services.
These interventions rarely attract the same attention as hospitals, procedures, or specialty services. In fee-for-service environments, they have historically struggled to secure consistent financial support because their value emerges indirectly rather than through a billable event.
This distinction matters because hospital care remains one of the largest drivers of healthcare spending. CMS reported that hospital expenditures exceeded $1.6 trillion in 2024, representing the single largest category of healthcare spending in the U.S. 1
Yet comparatively simple interventions can have a disproportionate impact. A transportation program may prevent a missed specialist appointment that leads to disease progression. A care manager may identify an emerging issue before it becomes an avoidable admission. A behavioral health intervention may reduce utilization across multiple care settings. Medication adherence support may prevent costly complications entirely.
The common thread is that these services create value primarily by preventing future expense rather than generating immediate revenue — and that distinction matters.
Under traditional reimbursement models, investment decisions naturally gravitate toward activities that can be measured through direct reimbursement. Under value-based arrangements, though, organizations gain greater ability to capture the benefit of prevention itself.
The question changes from, “Can we bill for this?” to, “Will this improve outcomes and prevent future utilization?”
When organizations begin evaluating investments based on avoided cost, improved outcomes, and reduced utilization rather than encounter volume alone, the economics of prevention become much easier to justify. For many healthcare leaders, that may represent one of the most significant strategic shifts occurring within healthcare today.
The hidden cost of fragmentation
Every healthcare executive understands the financial impact of fragmentation.
Patients frequently move between primary care practices, specialists, urgent care facilities, hospitals, post-acute settings, pharmacies, and community services. Every transition introduces risk, such as loss of information, unclear responsibilities, and gaps in follow-up care, while patients are frequently left to coordinate a system that was never designed for them to navigate alone.
The result is cost.
Duplicated testing, unnecessary utilization, delayed interventions, preventable admissions, and poorly coordinated care overlap and generate significant financial consequences.
The challenge is that fragmentation is often discussed as an operational problem when, fundamentally, patients experience fragmented care long before healthcare organizations experience fragmented finances.
Value-based care creates stronger incentives to solve for both. When organizations become accountable for outcomes over time, continuity and coordination become more valuable, and investments that help patients navigate the healthcare system become easier to justify because organizations share more directly in the benefits of successful coordination.
Once again, patient outcomes and financial outcomes become linked.
A more sustainable healthcare system starts earlier
Organizations continue to devote enormous resources after patients become sick. Far less investment has historically been directed toward keeping them from becoming sick enough to require the healthcare system’s most expensive services in the first place.
That imbalance affects everything, from cost and access to workforce capacity, patient experience, and physician satisfaction. Sustainability increasingly depends on what happens before patients require high-cost interventions.
The organizations performing best financially in value-based environments are often those deliberately investing in prevention, risk identification, coordination, and longitudinal patient management. They are not simply becoming better at managing utilization but at identifying risk earlier, understanding patient complexity more completely, coordinating care more effectively, and intervening before deterioration occurs.
Better outcomes change the economics
The economics improve because the outcomes improve.
Ultimately, that may be the most important lesson value-based care offers healthcare leaders.
Financial performance and patient outcomes are not competing ideas but reflections of the same underlying reality: how effectively a healthcare system helps people remain healthy before they become sick enough to require its most expensive services.
Value-based care creates incentives that make earlier intervention possible and gives healthcare organizations greater ability to invest in risk identification, care coordination, patient engagement, and longitudinal support that can improve outcomes before costly complications emerge.
Over time, those same investments help reduce unnecessary utilization and create a stronger foundation for long-term sustainability.
Sources
1 Centers for Medicare & Medicaid Services (CMS), National Health Expenditure Fact Sheet and 2024 Highlights
2 Kaiser Family Foundation (KFF), How Do Health Expenditures Vary Across the Population? (2026)
3 Centers for Medicare & Medicaid Services (CMS), National Health Expenditure by Age and Sex Data
The Commonwealth Fund, U.S. Health Care from a Global Perspective (2026)
The Commonwealth Fund, High U.S. Health Care Spending: Where Is It All Going? (2023)